BRIEF-European Medicines Agency accepts Basilea's Isavuconazole marketing authorization application for review

Thu Aug 21, 2014 2:07am EDT

Related Topics

Aug 21 (Reuters) - Basilea Pharmaceutica AG : * Says European Medicines Agency accepts Isavuconazole marketing authorization application for review * Seeks approval of Isavuconazole for treatment of invasive aspergillosis and

mucormycosis (zygomycosis) in adults * Source text for Eikon * Further company coverage

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.